Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens

J Vet Pharmacol Ther. 2005 Dec;28(6):575-80. doi: 10.1111/j.1365-2885.2005.00695.x.

Abstract

The pharmacokinetic properties of pentoxyfylline and its metabolites were determined in healthy chickens after single intravenous and oral dosage of 100 mg/kg pentoxyfylline. Plasma concentrations of pentoxyfylline and its metabolites were determined by a validated high-performance liquid chromatographic method. After intravenous (i.v.) and oral (p.o.) administration, the plasma concentration-time curves were best described by a one-compartment open model. The mean elimination half-life (t(1/2el)) of pentoxyfylline was 1.05 h, total body clearance 1.90 L/h x kg, volume of distribution 2.40 L/kg and the mean residence time was 2.73 h, after i.v. administration. After oral dosing, mean maximal plasma concentration of pentoxyfylline was 4.01 microg/mL and the interval from p.o. administration until maximum concentration was 1.15 h. The mean oral bioavailability was found to be 28.2%. Metabolites I, IV and V were present in chicken plasma after both i.v. and p.o. administration, with metabolite V being the most dominant.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / blood
  • Anti-Inflammatory Agents / pharmacokinetics*
  • Area Under Curve
  • Biological Availability
  • Chickens / metabolism*
  • Injections, Intravenous / veterinary
  • Pentoxifylline / administration & dosage
  • Pentoxifylline / blood
  • Pentoxifylline / pharmacokinetics*

Substances

  • Anti-Inflammatory Agents
  • Pentoxifylline